Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Copyright 2023 – Finance News Network
Source: Finance News Network
18 Aug 2022 - eCargo Holdings Limited (ASX:ECG) Group CEO Lawrence Lun discusses the rationale for the sale of digital consultancy company Amblique, how the proceeds will be used, and the roadmap for the coming months.
Read More16 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the company’s high-grade exploration results from its northern NSW project, plus how it’s poised to benefit from the rise of ‘critical minerals’ designation.
Read More30 Oct 2023 - Amanda Harsas, Finance Director of Atlantic Lithium (ASX:A11), discusses the company's flagship Ewoyaa Project in Ghana, its strategic partnerships, Ghanaian government support, and prospects for resource upgrades, providing insights into the burgeoning lithium industry in the region.
Read More06 Feb 2024 - Altech Batteries (ASX:ATC) reveals prototype, poised for final tests and government backing.
Read More29 Aug 2024 - Corella Resources Limited (ASX:CR9) CEO Jess Maddren provides an overview of the business, discussing novel steps for high-purity alumina flowsheeting.
Read More09 Jun 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, global growth and central bank decision-making.
Read More24 Jul 2023 - Magnis Energy Technologies Limited (ASX:MNS) Managing Director (US) Hoshi Daruwalla and Technical Advisory Committee members Dr Michael Osborne and Wade Guindy discuss progress, focusing on the company's lithium-ion battery manufacturing plant, iM3NY.
Read More01 Nov 2019 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig talks about FY19 results, trends strategy and FY20 outlook.
Read More27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More
